Q32 Bio
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.39-0.28-0.21-0.21
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$-4.59$-6.42$-8.54$-8.58

Historical Multiples (2016 – 2023)

2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-86.79-23.28-11.48-8.38-4.02-5.35-1.68-0.31N/A-6.20
Price/Sales ratio
N/AN/A119.95523.31191.835.9210.8730.40N/A357.57
Price/Book Value ratio
93.127.103.253.372.64-2.25-0.550.48N/A3.00
Price/Cash Flow ratio
-82.32107.80-14.99-9.54-5.49-6.10-6.60-0.36N/A-7.51
Price/Free Cash Flow ratio
-66.68154.49-9.45-7.70-5.28-6.07-5.38-0.36N/A-6.49
Price/Earnings Growth ratio
N/A-0.08-0.08-0.31-0.290.07-0.17-0.00N/A-0.30
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A100%100%100%71.90%60.92%50%N/A100%
Operating Profit Margin
N/AN/A-1126.00%-6599.21%-4820.98%-108.01%-589.76%-7967.30%N/A-5710.10%
Pretax Profit Margin
N/AN/A-1044.28%-6237.45%-4762.91%-108.96%-642.71%-7532.87%N/A-5500.18%
Net Profit Margin
N/AN/A-1044.28%-6237.45%-4762.91%-110.57%-643.64%-9771.71%N/A-5500.18%
Effective Tax Rate
N/AN/AN/AN/AN/A-1.47%-0.14%-29.72%N/AN/A
Return on Assets
-56.59%-21.80%-21.45%-33.46%-48.79%-106.86%-69.29%-36.90%N/A-41.12%
Return On Equity
-107.28%-30.50%-28.30%-40.19%-65.66%42.10%32.75%-154.76%N/A-52.93%
Return on Capital Employed
-127.53%-23.04%-25.33%-36.86%-54.03%-131.35%-1003.45%-31.26%N/A-45.45%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
1.8714.859.8421.549.694.600.777.25N/A15.61
Cash ratio
1.785.811.694.349.594.460.753.39N/A6.97
Days of Sales Outstanding
N/AN/A54.8687.6354.039.7658.39N/AN/A70.83
Days of Inventory outstanding
N/AN/AN/AN/AN/A29.40245.76N/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/A39.17304.15N/AN/AN/A
Days of Payables Outstanding
1.36K1.35KN/AN/AN/A102.34201.522.04KN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/A-63.16102.62-2.04KN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/A0.000.140.600.00N/A0.00
Debt Equity Ratio
N/AN/AN/AN/A0.01-0.05-0.280.01N/A0.00
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A-0.05-0.04N/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/A0.01-0.05-0.400.01N/A0.00
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/A-37.71-6.63-0.29-73.01N/A-18.85
Company Equity Multiplier
1.891.391.311.201.34-0.39-0.474.19N/A1.27
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-7.99-54.83-34.91-0.97-1.64-83.24N/A-44.87
Free Cash Flow / Operating Cash Flow Ratio
1.230.691.581.231.031.001.221.00N/A1.13
Cash Flow Coverage Ratio
N/AN/AN/AN/A-37.71-6.63-0.29-73.01N/A-18.85
Short Term Coverage Ratio
N/AN/AN/AN/A-37.71N/A-0.33-73.01N/A-18.85
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A